Use of radioactive iodine is an essential adjuvant treatment strategy after thyroidectomy in
patients with differentiated thyroid carcinoma. Although generally safe, radioiodine therapy …

Background Treatment of differentiated thyroid carcinoma (DTC) often involves
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …

Natural small molecule surfactants (lecithin and quillaja saponin) were used to fabricate
nanoemulsion-based delivery systems from vitamin E acetate using high pressure …

Background Postoperative radioactive iodine (RAI) administration is widely utilized in
patients with differentiated thyroid cancer. While beneficial in select patients, it is critical to …

Background Salivary gland dysfunction is an'umbrella'term for the presence of either
xerostomia (subjective sensation of dryness), or salivary gland hypofunction (reduction in …

Purpose This study aims to elaborate on the current knowledge concerning the mechanism,
frequency, clinical manifestations, diagnostic procedures, prevention, and management of …

Recent years have seen the start of treatment of metastatic castration-resistant prostate
cancer with prostate-specific membrane antigen (PSMA)–targeted radioligand therapy …

Introduction Salivary gland dysfunction (eg, sialadenitis and xerostomia) is the most
common complication of radioactive iodine (RAI) therapy for differentiated thyroid cancer …

In integrative medicine, well-being is emphasized, and in palliative care, quality of life (QOL)
is a similar concept or goal. Both can occur despite advanced cancer. Integrative medicine …

Objective: In the current study, we examined whether selenium supplementation during
iodine-131 (131I) treatment had a radio-protective effect on salivary glands. Subjects and …